Terns Pharmaceuticals, Inc. (TERN)
52.95
0.00 (0.00%)
USD |
NASDAQ |
May 06, 16:00
Terns Pharmaceuticals SG&A Expense (TTM) : 32.24M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Merck & Co., Inc. | 10.88B |
| Cogent Biosciences, Inc. | 51.68M |
| BioMarin Pharmaceutical, Inc. | 946.91M |
| Corcept Therapeutics, Inc. | 503.42M |
| ADMA Biologics, Inc. | 96.42M |